1. Home
  2. MBWM vs CRVS Comparison

MBWM vs CRVS Comparison

Compare MBWM & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mercantile Bank Corporation

MBWM

Mercantile Bank Corporation

HOLD

Current Price

$60.30

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$11.71

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBWM
CRVS
Founded
1997
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
1997
2016

Fundamental Metrics

Financial Performance
Metric
MBWM
CRVS
Price
$60.30
$11.71
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
★ $55.67
$30.17
AVG Volume (30 Days)
79.5K
★ 861.2K
Earning Date
04-21-2026
05-07-2026
Dividend Yield
★ 3.08%
N/A
EPS Growth
10.95
★ 48.04
EPS
★ 2.82
N/A
Revenue
N/A
N/A
Revenue This Year
$20.28
N/A
Revenue Next Year
$4.67
N/A
P/E Ratio
$21.11
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$42.75
$6.39
52 Week High
$62.95
$26.95

Technical Indicators

Market Signals
Indicator
MBWM
CRVS
Relative Strength Index (RSI) 50.33 34.36
Support Level $58.49 $11.13
Resistance Level $62.67 $14.00
Average True Range (ATR) 1.28 0.70
MACD -0.20 -0.13
Stochastic Oscillator 37.27 9.12

Price Performance

Historical Comparison
MBWM
CRVS

About MBWM Mercantile Bank Corporation

Mercantile Bank Corp operates as a bank holding company. It offers various commercial banking services to individuals, businesses, governmental units, and other institutions. These services include deposit products such as checking, savings, and term certificate accounts and lending products such as commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: